litlas
Log inCreate account

Walter Weder

Active 1990–2025

111
Papers
19,448
Citations
78
h-index
108
i10-index

Citations

Citations per year for Walter Weder1926: 1 citations1971: 3 citations1976: 1 citations1990: 2 citations1992: 1 citations1993: 2 citations1994: 2 citations1995: 1 citations1996: 1 citations1997: 6 citations1998: 18 citations1999: 28 citations2000: 27 citations2001: 33 citations2002: 38 citations2003: 60 citations2004: 76 citations2005: 88 citations2006: 76 citations2007: 82 citations2008: 98 citations2009: 118 citations2010: 88 citations2011: 103 citations2012: 105 citations2013: 155 citations2014: 148 citations2015: 157 citations2016: 172 citations2017: 117 citations2018: 116 citations2019: 444 citations2020: 468 citations2021: 497 citations2022: 381 citations2023: 280 citations2024: 490 citations2025: 225 citations2026: 3 citations1927–1970: no citations, so these years are not shown1972–1975: no citations, so these years are not shown1977–1989: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,633 citing papers, 22.8% of this breakdownChina: 745 citing papers, 10.4% of this breakdownUnited Kingdom: 448 citing papers, 6.2% of this breakdownGermany: 427 citing papers, 6% of this breakdownItaly: 413 citing papers, 5.8% of this breakdownJapan: 313 citing papers, 4.4% of this breakdownSwitzerland: 312 citing papers, 4.3% of this breakdownFrance: 309 citing papers, 4.3% of this breakdownNetherlands: 266 citing papers, 3.7% of this breakdownCanada: 258 citing papers, 3.6% of this breakdownSpain: 252 citing papers, 3.5% of this breakdownAustralia: 182 citing papers, 2.5% of this breakdown
0%22.8%Other 22.5%

Institutions

Fields

  • Medicine82.1%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Immunology and Microbiology2.7%
  • Engineering1.1%
  • Neuroscience0.6%
  • Materials Science0.6%
  • Other1.4%

Topics

  • Lung Cancer Diagnosis and Treatment9%
  • Lung Cancer Treatments and Mutations7.3%
  • Lung Cancer Research Studies6.4%
  • Radiomics and Machine Learning in Medical Imaging4%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Pleural and Pulmonary Diseases3.1%
  • Other66.7%

Coauthors

All papers

Open in search
  1. Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    Authors: Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris, Tina Cascone - Nature Reviews Clinical Oncology 2021 cited by 391

  2. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Authors: William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 cited by 450

  3. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Authors: Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, Julie George, Danila Seidel, Lawryn H. Kasper, Dennis Plenker, Frauke Leenders, Ruping Sun, Thomas Zander, Roopika Menon, Mirjam Koker, Ilona Dahmen, Christian Müller, Vincenzo Di Cerbo, Hans‐Ulrich Schildhaus, Janine Altmüller, Ingelore Baessmann, Christian Becker, Bram De Wilde, Jo Vandesompele, Diana Böhm, Sascha Ansén, Franziska Gabler, Ines Wilkening, Stefanie Heynck, Johannes M. Heuckmann, Xin Lü, Scott L. Carter, Kristian Cibulskis, Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 cited by 1,418

  4. Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

    Authors: Tina Cascone, Gozde Kar, Jonathan Spicer, Rosario García-Campelo, Walter Weder, Davey B. Daniel, David R. Spigel, Maen Hussein, Julien Mazières, Júlio Oliveira, Edwin Yau, Alexander I. Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin‐Yang Cheng, Ying Zheng, Jorge Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez‐Canales, Vancheswaran Gopalakrishnan, Bret R. Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M. Forde - Cancer Discovery 2023 cited by 117

  5. SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial

    Authors: Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet, Spasenija Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Didier Lardinois, Hans Gelpke, Laetitia Mauti, Christian Britschgi, Walter Weder, Solange Peters, Michael Mark, Richard Cathomas, Adrian F. Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Gilles Godar, Corinne Rusterholz, Michel González, Miklos Pless - Journal of Clinical Oncology 2021 cited by 341

  6. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

    Authors: Paul De Leyn, Christophe Dooms, J. Kuzdzal, Didier Lardinois, Bernward Passlick, Ramón Rami–Porta, Akif Turna, Paul Van Schil, Federico Venuta, David Waller, Walter Weder, Marcin Zieliński - European Journal of Cardio-Thoracic Surgery 2014 cited by 831

  7. Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA

    Authors: Masahiro Tsuboi, Walter Weder, Carles Escriu, Collin M. Blakely, Jianxing He, Sanja Đačić, Yasushi Yatabe, Lingmin Zeng, Andrew Walding, Jamie E. Chaft - Future Oncology 2021 cited by 189

  8. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

    Authors: Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noémie Leblay, Graham Byrnes, Ruping Sun, Aurélien de Reyniès, Anne McLeer‐Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James McKay, Denis Moro‐Sibilot, Christian Brambilla, Sylvie Lantuéjoul, Nicolas Lemaître, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund‐Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, D. Neil Hayes, Élisabeth Brambilla, Lynnette Fernandez‐Cuesta, Roman K. Thomas - Nature Communications 2018 cited by 373

  9. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

    Authors: Stefanie Hiltbrunner, Christian Britschgi, Petra Schuberth, Lorenz Bankel, Thi Dan Linh Nguyen‐Kim, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Hans Bachmann, Annett Tabor, Petra Schröder, Alexander Knuth, Christian Münz, Rolf A. Stahel, Onur Boyman, Christoph Renner, Ulf Petrausch, Alessandra Curioni‐Fontecedro - Annals of Oncology 2020 cited by 88

  10. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

    Authors: Miklos Pless, Roger Stupp, Hans-Beat Ris, Rolf A. Stahel, Walter Weder, Sandra Thierstein, Marie-Aline Gérard, Alexandros Xyrafas, Martin Früh, Richard Cathomas, Alfred Zippelius, Arnaud Roth, Milorad Bijelović, Adrian F. Ochsenbein, Urs R. Meier, Christoph Mamot, Daniel Rauch, Oliver Gautschi, Daniel Betticher, René-Olivier Mirimanoff, Solange Peters - The Lancet 2015 cited by 390

  11. A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

    Authors: A. Curioni, Christian Britschgi, Stefanie Hiltbrunner, Lorenz Bankel, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Alexander Knuth, Christian Münz, C. Renner, Rolf A. Stahel, Ulf Petrausch - Annals of Oncology 2019 cited by 53

  12. Influence of inter-observer delineation variability on radiomics stability in different tumor sites

    Authors: Matea Pavic, Marta Bogowicz, Xaver Würms, S. Glatz, Tobias Finazzi, Oliver Riesterer, Johannes Roesch, Leonie Rudofsky, Martina Friess, Patrick Veit‐Haibach, Martin W. Huellner, Isabelle Opitz, Walter Weder, Thomas Frauenfelder, Matthias Gückenberger, Stephanie Tanadini‐Lang - Acta Oncologica 2018 cited by 200

  13. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    Authors: Wilfried Eberhardt, Dirk De Ruysscher, Walter Weder, C. Le Péchoux, Paul De Leyn, H. Hoffmann, Virginie Westeel, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2015 cited by 398

  14. Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

    Authors: Ulf Petrausch, Petra Schuberth, Christian Hagedorn, Alex Soltermann, Sandra Tomaszek, Rolf A. Stahel, Walter Weder, Christoph Renner - BMC Cancer 2012 cited by 90

  15. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database

    Authors: Valerie W. Rusch, Dorothy J. Giroux, Catherine Kennedy, Enrico Ruffini, Ayten Cangır, David C. Rice, Harvey I. Pass, Hisao Asamura, David Waller, John Edwards, Walter Weder, Hans Hoffmann, Jan P. van Meerbeeck - Journal of Thoracic Oncology 2012 cited by 401

  16. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

    Authors: Daniel Betticher, Shu‐Fang Hsu Schmitz, Martin Tötsch, Eva Støttrup Hansen, Christine Joss, Christian von Briel, Ralph A. Schmid, Miklos Pless, James Habicht, Arnaud Roth, Anastase Spiliopoulos, Rolf A. Stahel, Walter Weder, Roger Stupp, F Egli, Markus Furrer, Hanspeter Honegger, Martin Wernli, Thomas Cerny, Hans-Beat Ris - Journal of Clinical Oncology 2003 cited by 455

  17. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)

    Authors: Georgios Stamatis, Gunda Leschber, Birte Schwarz, Diana Lütke Brintrup, Claudia Ose, Gerhard Weinreich, Bernward Passlick, E. Hecker, Christian Kügler, Hendrik Dienemann, Thomas Krbek, Stephan Eggeling, Rudolf Hatz, Michael Müller, Walter Weder, Clemens Aigner, Karl‐Heinz Jöckel - Lung Cancer 2019 cited by 77

  18. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer

    Authors: Alex Soltermann, Verena Tischler, Stefanie Arbogast, Julia Braun, Nicole Probst‐Hensch, Walter Weder, Holger Moch, Glen Kristiansen - Clinical Cancer Research 2008 cited by 271

  19. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

    Authors: Benjamin Besse, A. Adjei, P. Baas, Peter Meldgaard, M. Nicolson, Luis Paz‐Ares, Martin Reck, Egbert F. Smit, Konstantinos Syrigos, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2014 cited by 247

  20. Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

    Authors: Kathrin Oehl, Bart Vrugt, Ulrich Wagner, Michaela B. Kirschner, Mayura Meerang, Walter Weder, Emanuela Felley‐Bosco, Bernd Wollscheid, Katrin Bankov, Melanie Demes, Isabelle Opitz, Peter J. Wild - Clinical Cancer Research 2021 cited by 43

  21. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

    Authors: David König, Sämi Schär, Diem Vuong, Matthias Gückenberger, Katarzyna Furrer, Isabelle Opitz, Walter Weder, Sacha I. Rothschild, Adrian F. Ochsenbein, Alfred Zippelius, Alfredo Addeo, Michael Mark, E.I. Eboulet, Stefanie Hayoz, Sandra Thierstein, Daniel Betticher, H.-B. Ris, Roger Stupp, Alessandra Curioni‐Fontecedro, Solange Peters, Miklos Pless, Martin Früh - ESMO Open 2022 cited by 24

  22. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review

    Authors: Collin M. Blakely, Walter Weder, Lukas Bubendorf, Jianxing He, Margarita Majem, Yu Shyr, Jamie E. Chaft - Lung Cancer 2023 cited by 22

  23. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Lucio Crinò, Walter Weder, Jan P. van Meerbeeck, Enriqueta Felip - Annals of Oncology 2010 cited by 539

  24. Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience

    Authors: Christian Benden, Rudolf Speich, Günther F.L. Hofbauer, Sarosh R. Irani, Christine Eich-Wanger, Erich W. Russi, Walter Weder, Annette Boehler - Transplantation 2008 cited by 161